Related Experiment Videos
Depression and alcohol use disorders: is the road twice as long or twice as steep?
1Brown University School of Medicine, Department of Psychiatry and Human Behavior, Butler Hospital, Providence, RI 02906, USA.
Harvard Review of Psychiatry
|August 10, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes.
Alcoholism, clinical and experimental research·2001
Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence.
The American journal on addictions·2001
A brief assessment of psychosocial functioning of subjects with bipolar I disorder: the LIFE-RIFT. Longitudinal Interval Follow-up Evaluation-Range Impaired Functioning Tool.
The Journal of nervous and mental disease·2001
Predictors of compliance with naltrexone among alcoholics.
Alcoholism, clinical and experimental research·2000
Psychosocial disability during the long-term course of unipolar major depressive disorder.
Archives of general psychiatry·2000
Using Islamic Mindfulness-Based Interventions as a Compass for Improving Muslim Mental Health Outcomes: A Scoping Review.
Harvard review of psychiatry·2026
What Psychiatry Measures, and What It Misses: Flourishing as a Blind Spot in Patient-Centered Care.
Harvard review of psychiatry·2026
Beyond Symptom Recognition: Toward a Comprehensive Multidimensional Framework of Insight in Depression.
Harvard review of psychiatry·2026
Inpatient Curbside Consultation in Psychiatry: A Primer.
Harvard review of psychiatry·2026
Observational study: Sales of Cannabis with flavor-indicating names by purchaser age in California 2020-2021.
The International journal on drug policy·2026
Alcohol and energy drink co-use among commercial drivers in Ghana: A dangerous mix for occupational health and safety.
Traffic injury prevention·2026
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease.
Movement disorders clinical practice·2026
AI product liability under EU and Canadian laws.
Frontiers in artificial intelligence·2026